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Due to the aging of the population, the prevalence of chronic
diseases is progressively increasing and most older adults
experience the cooccurrence ofmultiple diseases, a condition
known as multimorbidity. It has been estimated that 60% of
persons aged 65 years or older are affected bymultimorbidity,
the reason why the condition is sometimes referred to as the
“most common chronic disease” [1]. The appearance of clus-
ters and patterns of patients and diseases in different context
and populations group has been also demonstrated [2, 3].
Advanced age, female gender, low socioeconomic status, and
education are among the main risk factors for the develop-
ment of multimorbidity.This suggests, for example, that early
life learned risk behaviours may affect the development of
this condition [2]. Compared to those with single conditions,
persons with multimorbidity are more likely to experience
negative health outcomes, including mortality, hospitaliza-
tion, and functional and cognitive decline, leading ultimately
to poorer quality of life and increased care costs. Persons with
multimorbidity have the most complex health needs but, due
to the current disease-oriented approach in healthcare, they
face highly fragmented care that leads to incomplete, ineffi-
cient, ineffective, and even potentially harmful interventions
[4].
In this special issue, investigators reported studies into
the subject from all over the world (i.e., Canada, India,
Panama, Portugal, Netherlands, and UK). They contributed
to increasing the knowledge on multimorbidity by focusing
on clustering of chronic diseases and methods to evalu-
ate multimorbidity and its impact on clinical outcomes,
including functional status, quality of life, compliance to
physical activity, depression, and cognitive impairment.
Sanghamitra Pati and colleagues described and validated a
new tool for multimorbidity assessment in India. Although
it is known that low and middle income countries with
socioeconomic development and westernization of lifestyle
are no longer “immune” to multimorbidity, multimorbidity
is still underexplored in these countries. This study defini-
tively contributed to estimating the magnitude and impact
of multimorbidity in primary care practice populations in
developing countries. Joanna Collerton and colleagues exam-
ined the extent and complexity of the morbidity burden in
the Newcastle 85+ Study, a population-based cohort study.
The authors used cluster analysis to identify patterns of
diseases within multimorbidity and to compare clusters on
medication and healthcare use. A cluster approach was used
also by Sarah Do¨renkamp and colleagues.Their objective was
to identify clusters ofmultimorbidity associatedwith physical
activity, using data from the Dutch cohort study SMILE.
They evidenced that the lowest rate of physical activity and
guideline compliance was reported in patients with heart
disease, respiratory disease, and diabetes mellitus. Several
potential uses of a cluster medicine approach deserve to be
highlighted: (1) New research hypotheses on possible shared
pathological pathway for clusters of specific diseases can be
developed. (2) Prevention can be implemented. (3) Groups of
people at high risk of adverse outcomes can be identified. (4)
Prevalence of use of potentially inappropriate medication or
adverse drug reactions could be higher in different clusters.
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(5) Clinical trials could be carried out in groups of the
elderly affected by specific clusters of diseases. (6) Treatment
can be better tailored to the individual person because it
enables actively evaluating the presence of and dealing with
comorbidities known to cooccur. (7) Finally, the severity of
a disease can be approximated by its connections with other
diseases for patientswith the samenumber of diagnoses [3, 5].
Filipe Prazeres and colleagues described the translation
of the European General Practice Research Network Mul-
timorbidity definition according to Portuguese cultural and
linguistic features. The definition of multimorbidity is now
available in a new language, Portuguese. The operationaliza-
tion of the definition and its availability in the local language
will raise Portuguese GPs’ awareness about multimorbidity
and allow future national and international research. Villar-
real and colleagues reported first data on the association of
multimorbidity with the cooccurrence of cognitive impair-
ment and depression alone in older persons living in Panama.
In the older population, depression is frequent and it also
commonly coexists with other chronic medical conditions.
On one hand, chronic diseases increase the risk of depression
due to the presence of disability, pain, and polypharmacy
in multimorbid persons. On the other hand, depression
can negatively affect adherence to medications and to a
healthy lifestyle that are needed to prevent other clinical
conditions.This points at the complexities underlying disease
cooccurrence and the mechanism of reciprocity, which is
a phenomenon that is perhaps understudied in medicine
to understand the relationships between determinants and
outcomes. Finally, Aline Ramond-Roquin and colleagues
evaluated the association between different multimorbidity
measures and physical quality of life. Studies aiming to
quantify the impact of multimorbidity on quality of life
showed wide heterogeneity in terms of the intensity of this
association. It has been suggested that the lack of a uniform
way to measure multimorbidity may explain a significant
part of this variability. The length of the list of candidate
conditions considered has a great impact on the estima-
tions of physical health-related quality of life. The selection
of different methods to measure multimorbidity is critical
in determining both prevalence of multimorbidity and its
association with the outcome of interest. The simple count of
diseases has both advantages and disadvantages. A relevant
advantage of this approach is that it expresses multimorbidity
in an additive form, and it conveniently differentiates people
at each level of morbidity. Second, each individual disease
contributes to the disease count, avoiding problems of insuffi-
cient statistical power, especially if rare diseases are evaluated.
On the contrary, one of the most reported disadvantages is
that all diseases are scored equally, independently of their
severity.
Despite the increasing interest of the researchers in this
field, there is still a remarkable gap between the harmful
impact of multimorbidity at the individual and societal level
and the amount of scientific and clinical research devoted to
this topic. Contributions to this special issue filled some gaps
in the field providing useful tools to measure multimorbidity
and data exploring the prevalence, type, and impact of the
presence of multiple cooccurring diseases.
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